DIAGNOSTIC RADIOISOTOPES MARKET ANALYSIS

Diagnostic Radioisotopes Market, By Radioisotope (Technetium-99m, Thallium-201, Gallium-67, Iodine-123, FDG, Rubidium-82, Others ), By Application (Diagnostic Application and Therapeutic Application), By Imaging Modality (SPECT, PET, Beta Emitters), By Disease Indication (Oncology, Cardiology, Neurology, Thyroid, Orthopedic, Endocrinology, Others), By End User (Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes, Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

Published In : Nov 2023
Code : CMI6190
Pages :145
Formats :
Excel and PDF
Industry : Medical Devices

Market Size and Trends

Global diagnostic radioisotopes market size is expected to reach US$ 10.36 Bn by 2030, from US$ 5.67 Bn in 2023, at a CAGR of 9% during the forecast period. Diagnostic radioisotopes are radioactive elements that are used for medical imaging to diagnose various diseases like cancer, cardiovascular diseases, neurological disorders etc. these help in early and accurate disease diagnosis. Global diagnostic radioisotopes market is segmented by radioisotope, application, imaging modality, end user, indication and region. By radioisotope, the market is segmented into Technetium-99m, Thallium-201, Gallium-67 and others. Technetium-99m is the largest segment due to its wide usage in nuclear medicine diagnostics.

Diagnostic Radioisotopes Market Report Snapshots